Healthcare

WELL’s Subsidiary Wisp Launches Comprehensive Weight Care Vertical Inclusive of GLP-1 Medications to Support Women Struggling with Hormonal Imbalances

Wisp debuts its first-ever exclusive over-the-counter weight-loss supplement, designed to promote women's metabolic health.Wisp introduces personalized, online consultations with access…

3 months ago

Google Cloud Launches General Availability of Vertex AI Search for Healthcare and Healthcare Data Engine

Google Cloud's solutions help healthcare organizations improve medical systems and provide better care SUNNYVALE, Calif., Oct. 17, 2024 /PRNewswire/ --…

3 months ago

IgniteData Secures Enterprise Agreement for Archer Platform, Streamlining EHR-to-EDC Data Transfer

WILMINGTON, Del., Oct. 17, 2024 /PRNewswire/ -- IgniteData, a company focused on healthcare technology solutions, announces a new collaboration with…

3 months ago

New Study from Google Cloud and The Harris Poll Reports How Generative AI Can Tackle Administrative Burdens in U.S. Healthcare

Study also outlines how gen AI can improve medical systems and help doctors and nurses provide better care SUNNYVALE, Calif.,…

3 months ago

Health eCareers and the Pediatric Infectious Diseases Society Announce Partnership

This partnership provides career opportunities for pediatric infectious diseases specialists by creating connections with employers nationwide.NEW YORK, NY / ACCESSWIRE…

3 months ago

Justera Health Completes Acquisition of Popular Cannabis Brand, Port North

TORONTO, ON / ACCESSWIRE / October 17, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"orthe"Company") is pleased to announce the…

3 months ago

Intercept Provides Regulatory Update Regarding sNDA for OCALIVA

MORRISTOWN, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned subsidiary of Alfasigma S.p.A., today announced…

3 months ago

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is…

3 months ago